ENGLAND, UK

Fordham Lab (Analytical Sciences)

Founded in 1997

Our Fordham site has two purpose-built, state-of-the-art analytical laboratories.

Lab Description

Analytical Sciences Fordham and its teams are divided between two laboratory areas, Separation Sciences and Elemental Analysis.

Separation Sciences is subdivided into discrete Sample Management, Wet Chemistry, and Instrument areas to enable efficient working.

Elemental Analysis is access-controlled and under positive pressure to reduce possible contamination issues.

Resolian Analytical Sciences Fordham
Newmarket Road, Fordham, Ely, CB7 5WW 

Instrumentation

Examples of instrumentation available at the site are listed below:

LC-MS Instruments
  • Waters Acquity Premier 2D-UPLC with Waters Xevo G2-XS TOF-MS
  • Waters Acquity UPLC with Waters Synapt G2 Q-TOF-MS
  • Waters Acquity UPLC with Waters Xevo TQ-S Triple Quadrupole MS
  • Waters Acquity UPLC with Sciex API6500+ Triple Quadrupole MS
  • Waters Acquity UPLC with Sciex API5500 Triple Quadrupole MS
  • Waters Acquity UPLC with Sciex API4000 Triple Quadrupole MS
GC Instruments
  • Agilent 6890 GC-FID/ECD
SFC Instruments
  • Water UPC2 SFC
GC-MS Instruments
  • Agilent 7890B GC with Agilent 5977 MSD
  • Agilent 7890A GC with Agilent 5975C MSD
LC Instruments
  • Agilent 1100 HPLC
  • Agilent 1200 HPLC
Elemental Instruments
  • Agilent 7700 ICP-MS
  • Agilent 7900 ICP-MS
  • Thermo iCAP 7600 ICP-OES

See Our Other Labs

Chongqing Lab

See Chongqing Lab

Sandwich Lab

See Sandwich Lab

Malvern Lab

See Malvern Lab

Brisbane Lab

See Brisbane Lab

Fordham Lab (Bioanalytics)

See Fordham Lab (Bioanalytics)

For the latest news, visit our LinkedIn

Visit LinkedIn

For the latest Events, visit our Events page

Visit Events

Copyright © 2024 Resolian Inc. All rights reserved.

Scroll to Top

Zhiyang Zhao, Ph.D.

Chief Scientific Officer

Linkedin

Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade. 

Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia. 

Patrick Bennett

Chief Executive Officer

Linkedin

Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now CEO at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD. 

Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.